Computer assisted detection for mammography first entered the scene in the late 1990s. Approval by the FDA with subsequent granting of increased reimbursement for the use of CAD by Medicare launched adoption of this technology into hospitals and imaging centers across North America.
Magnetic resonance imaging of the breast serves a unique and important function in the battle against breast cancer. This adjunct to mammography and ultrasound often provides vital information for specific circumstances, such as screening women at high risk of breast cancer, and computer aided detection (CAD) for MRI enables additional valuable clinical insight.
By combining SPECT with CT images, a number of different diagnosticstudies are enhanced, including tumor volume renderings, pinpointingthe site of an infection, myocardial perfusion imaging and in thesearch for distant metastases in advanced forms of cancer. Oncology andcardiology are the primary benefactors of this technology.
The latest versions of hybrid PET/CT machines merge high-resolutionPET technology with multidetector CT scanners to produce fused imagesthat improve various aspects of patient care in oncology, cardiologyand neurology.
Remarkable advances in multidetector CT angiography (CTA) not onlyhave produced great excitement among both radiology and cardiologyspecialty groups but also have raised issues of responsibility forinterpretation of the resulting images.